Top

Clinical Reviews in Allergy & Immunology

Published in:

01-06-2020

Mast Cell Biology at Molecular Level: a Comprehensive Review

Authors: Daniel Elieh Ali Komi, Stefan Wöhrl, Leonard Bielory

Published in: Clinical Reviews in Allergy & Immunology | Issue 3/2020

Abstract

Mast cells (MCs) are portions of the innate and adaptive immune system derived from bone marrow (BM) progenitors that are rich in cytoplasmic granules. MC maturation, phenotype, and function are determined by their microenvironment. MCs accumulate at inflammatory sites associated with atopy, wound healing, and malignancies. They interact with the external environment and are predominantly located in close proximity of blood vessels and sensory nerves. MCs are key initiators and modulators of allergic, anaphylactic, and other inflammatory reactions, by induction of vasodilation, promoting of vascular permeability, recruitment of inflammatory cells, facilitation of adaptive immune responses, and modulation of angiogenesis, and fibrosis. They express a wide range of receptors, e.g., for IgE (FcεRI), IgG (FcγR), stem cell factor (SCF) (KIT receptor or CD117), complement (including C5aR), and cytokines, that upon activation trigger various signaling pathways. The final consequence of such ligand receptor–based activation of MCs is the release of a broad array of mediators which are classified in three categories. While some mediators are preformed and remain stored in granules such as heparin, histamine, and enzymes mainly chymase and tryptase, others are de novo synthesized only after activation including LTB4, LTD4, PDG2, and PAF, and the cytokines IL-10, IL-8, IL-5, IL-3, IL-1, GM-CSF, TGF-β, VEGF, and TNF-α. Depending on the stimulus, MCs calibrate their pattern of mediator release, modulate the amplification of allergic inflammation, and are involved in the resolution of the immune responses. Here, we review recent findings and reports that help to understand the MC biology, pathology, and physiology of diseases with MC involvement.

Crivellato E, Beltrami C, Mallardi F, Ribatti D (2003) Paul Ehrlich’s doctoral thesis: a milestone in the study of mast cells. Br J Haematol 123(1):19–21PubMed

Seneviratne SL, Maitland A (2017) Mast cell disorders in. Ehlers-Danlos Syndrome 175(1):226–236. https://doi.org/10.1002/ajmg.c.31555

Friberg U, Graf W, Aberg B (1951) On the histochemistry of the mast cells. Acta Pathol Microbiol Scand 29(2):197–202PubMed

Leclere M, Desnoyers M, Beauchamp G, Lavoie JP (2006) Comparison of four staining methods for detection of mast cells in equine bronchoalveolar lavage fluid. J Vet Intern Med 20(2):377–381PubMed

Muller T (1994) Supravital uptake of cationic dyes by mast cell granules: a light and electron microscope study. Biotech Histochem Off Publ Biol Stain Comm 69(3):171–176

Goldstein SM, Kaempfer CE, Kealey JT, Wintroub BU (1989) Human mast cell carboxypeptidase. Purification and characterization. J Clin Invest 83(5):1630–1636. https://doi.org/10.1172/jci114061 PubMedPubMedCentral

Gibson S, Miller HR (1986) Mast cell subsets in the rat distinguished immunohistochemically by their content of serine proteinases. Immunology 58(1):101–104PubMedPubMedCentral

Bulfone-Paus S, Bahri R (2015) Mast cells as regulators of T cell responses. Front Immunol 6:394. https://doi.org/10.3389/fimmu.2015.00394 PubMedPubMedCentral

Beaven MA (2009) Our perception of the mast cell from Paul Ehrlich to now. Eur J Immunol 39(1):11–25. https://doi.org/10.1002/eji.200838899 PubMedPubMedCentral

10.

Kinet JP (1999) The high-affinity IgE receptor (fc epsilon RI): from physiology to pathology. Annu Rev Immunol 17:931–972. https://doi.org/10.1146/annurev.immunol.17.1.931 PubMed

11.

Frandji P, Tkaczyk C, Oskeritzian C, David B, Desaymard C, Mecheri S (1996) Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur J Immunol 26(10):2517–2528. https://doi.org/10.1002/eji.1830261036 PubMed

12.

Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A (1987) Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6(11):3341–3351PubMedPubMedCentral

13.

Williams DE, Eisenman J, Baird A, Rauch C, Van Ness K, March CJ, Park LS, Martin U, Mochizuki DY, Boswell HS et al (1990) Identification of a ligand for the c-kit proto-oncogene. Cell 63(1):167–174PubMed

14.

Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD (1995) Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A 92(23):10560–10564PubMedPubMedCentral

15.

Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ (2005) Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167(3):835–848. https://doi.org/10.1016/s0002-9440(10)62055-x PubMedPubMedCentral

16.

Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2(5):561–566PubMed

17.

McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M, Dong X (2015) Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 519(7542):237–241. https://doi.org/10.1038/nature14022 PubMed

18.

Ginsburg H, Lagunoff D (1967) The in vitro differentiation of mast cells. Cultures of cells from immunized mouse lymph nodes and thoracic duct lymph on fibroblast monolayers. J Cell Biol 35(3):685–697PubMedPubMedCentral

19.

Ishizaka K, Ishizaka T, Hornbrook MM (1966) Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. J Immunol (Baltimore, Md : 1950) 97(6):840–853

20.

Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD (1999) Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 94(7):2333–2342PubMed

21.

Young JD, Liu CC, Butler G, Cohn ZA, Galli SJ (1987) Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci U S A 84(24):9175–9179PubMedPubMedCentral

22.

Nakano T, Sonoda T, Hayashi C, Yamatodani A, Kanayama Y, Yamamura T, Asai H, Yonezawa T, Kitamura Y, Galli SJ (1985) Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 162(3):1025–1043PubMed

23.

Edwards AM (2005) The discovery of cromolyn sodium and its effect on research and practice in allergy and immunology. J Allergy Clin Immunol 115(4):885–888. https://doi.org/10.1016/j.jaci.2005.01.063 PubMed

24.

Dudeck A, Dudeck J, Scholten J, Petzold A, Surianarayanan S, Kohler A, Peschke K, Vohringer D, Waskow C, Krieg T, Muller W, Waisman A, Hartmann K, Gunzer M, Roers A (2011) Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34(6):973–984. https://doi.org/10.1016/j.immuni.2011.03.028 PubMed

25.

Otsuka A, Kubo M, Honda T, Egawa G, Nakajima S, Tanizaki H, Kim B, Matsuoka S, Watanabe T, Nakae S, Miyachi Y, Kabashima K (2011) Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLoS One 6(9):e25538. https://doi.org/10.1371/journal.pone.0025538 PubMedPubMedCentral

26.

Lilla JN, Chen CC, Mukai K, BenBarak MJ, Franco CB, Kalesnikoff J, Yu M, Tsai M, Piliponsky AM, Galli SJ (2011) Reduced mast cell and basophil numbers and function in Cpa3-Cre; mcl-1fl/fl mice. Blood 118(26):6930–6938. https://doi.org/10.1182/blood-2011-03-343962 PubMedPubMedCentral

27.

Reber LL, Sibilano R, Mukai K, Galli SJ (2015) Potential effector and immunoregulatory functions of mast cells in mucosal immunity. Mucosal Immunol 8(3):444–463. https://doi.org/10.1038/mi.2014.131 PubMedPubMedCentral

28.

Gri G, Frossi B, D’Inca F, Danelli L, Betto E, Mion F, Sibilano R, Pucillo C (2012) Mast cell: an emerging partner in immune interaction. Front Immunol 3:120. https://doi.org/10.3389/fimmu.2012.00120 PubMedPubMedCentral

29.

Gilfillan AM, Austin SJ, Metcalfe DD (2011) Mast cell biology: introduction and overview. Adv Exp Med Biol 716:2–12. https://doi.org/10.1007/978-1-4419-9533-9_1 PubMedPubMedCentral

30.

Nocka K, Buck J, Levi E, Besmer P (1990) Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J 9(10):3287–3294PubMedPubMedCentral

31.

Campillo-Navarro M, Chavez-Blanco AD, Wong-Baeza I, Serafin-Lopez J, Flores-Mejia R, Estrada-Parra S, Estrada-Garcia I, Chacon-Salinas R (2014) Mast cells in lung homeostasis: beyond type I hypersensitivity. Current Respiratory Medicine Reviews 10(2):115–123. https://doi.org/10.2174/1573398x10666141024220151 PubMedPubMedCentral

32.

Kalesnikoff J, Galli SJ (2008) New developments in mast cell biology. Nat Immunol 9(11):1215–1223. https://doi.org/10.1038/ni.f.216 PubMedPubMedCentral

33.

Ronnberg E, Melo FR, Pejler G (2012) Mast cell proteoglycans. J Histochem Cytochem Off J Histochem Soc 60(12):950–962. https://doi.org/10.1369/0022155412458927

34.

Vogel P, Janke L, Gravano DM, Lu M, Sawant DV, Bush D, Shuyu E, Vignali DAA, Pillai A, Rehg JE (2018) Globule leukocytes and other mast cells in the mouse intestine. Vet Pathol 55(1):76–97. https://doi.org/10.1177/0300985817705174 PubMed

35.

Metcalfe DD, Baram D, Mekori YA (1997) Mast cells. Physiol Rev 77(4):1033–1079. https://doi.org/10.1152/physrev.1997.77.4.1033 PubMed

36.

Nakahata T, Kobayashi T, Ishiguro A, Tsuji K, Naganuma K, Ando O, Yagi Y, Tadokoro K, Akabane T (1986) Extensive proliferation of mature connective-tissue type mast cells in vitro. Nature 324(6092):65–67. https://doi.org/10.1038/324065a0 PubMed

37.

Tsuji K, Nakahata T, Takagi M, Kobayashi T, Ishiguro A, Kikuchi T, Naganuma K, Koike K, Miyajima A, Arai K et al (1990) Effects of interleukin-3 and interleukin-4 on the development of “connective tissue-type” mast cells: interleukin-3 supports their survival and interleukin-4 triggers and supports their proliferation synergistically with interleukin-3. Blood 75(2):421–427PubMed

38.

Enerback L, Lundin PM (1974) Ultrastructure of mucosal mast cells in normal and compound 48-80-treated rats. Cell Tissue Res 150(1):95–105PubMed

39.

Okabe T, Hide M, Hiragun T, Morita E, Koro O, Yamamoto S (2006) Bone marrow derived mast cell acquire responsiveness to substance P with ca(2+) signals and release of leukotriene B(4) via mitogen-activated protein kinase. J Neuroimmunol 181(1–2):1–12. https://doi.org/10.1016/j.jneuroim.2006.07.011 PubMed

40.

Galli SJ, Borregaard N, Wynn TA (2011) Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 12(11):1035–1044. https://doi.org/10.1038/ni.2109 PubMedPubMedCentral

41.

Pejler G, Abrink M, Ringvall M, Wernersson S (2007) Mast cell proteases. Adv Immunol 95:167–255. https://doi.org/10.1016/s0065-2776(07)95006-3 PubMed

42.

Irani AM, Bradford TR, Kepley CL, Schechter NM, Schwartz LB (1989) Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem Off J Histochem Soc 37(10):1509–1515. https://doi.org/10.1177/37.10.2674273

43.

Schwartz LB, Irani AM, Roller K, Castells MC, Schechter NM (1987) Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol (Baltimore, Md : 1950) 138(8):2611–2615

44.

Oliani SM, Vugman I, Jamur MC (1993) Ultrastructural similarity between bat and human mast cell secretory granules. Int Arch Allergy Immunol 100(3):230–233. https://doi.org/10.1159/000236416 PubMed

45.

Weidner N, Austen KF (1991) Ultrastructural and immunohistochemical characterization of normal mast cells at multiple body sites. The Journal of Investigative Dermatology 96(3):26S–30S discussion 30S-31SPubMed

46.

Frossi B, Mion F, Sibilano R, Danelli L, Pucillo CEM (2018) Is it time for a new classification of mast cells? What do we know about mast cell heterogeneity? Immunol Rev 282(1):35–46. https://doi.org/10.1111/imr.12636 PubMed

47.

Dahlin JS, Ding Z, Hallgren J (2015) Distinguishing mast cell progenitors from mature mast cells in mice. Stem Cells Dev 24(14):1703–1711. https://doi.org/10.1089/scd.2014.0553 PubMedPubMedCentral

48.

Guiraldelli MF, Franca CN, de Souza DA Jr, da Silva EZ, Toso VD, Carvalho CC, Jamur MC, Oliver C (2013) Rat embryonic mast cells originate in the AGM. PLoS One 8(3):e57862. https://doi.org/10.1371/journal.pone.0057862 PubMedPubMedCentral

49.

Jamur MC, Moreno AN, Mello LF, Souza Junior DA, Campos MR, Pastor MV, Grodzki AC, Silva DC, Oliver C (2010) Mast cell repopulation of the peritoneal cavity: contribution of mast cell progenitors versus bone marrow derived committed mast cell precursors. BMC Immunol 11:32. https://doi.org/10.1186/1471-2172-11-32 PubMedPubMedCentral

50.

Kitamura Y, Shimada M, Hatanaka K, Miyano Y (1977) Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 268(5619):442–443PubMed

51.

Gurish MF, Tao H, Abonia JP, Arya A, Friend DS, Parker CM, Austen KF (2001) Intestinal mast cell progenitors require CD49dbeta7 (alpha4beta7 integrin) for tissue-specific homing. J Exp Med 194(9):1243–1252PubMedPubMedCentral

52.

Oren M, Escande ML, Paz G, Fishelson Z, Rinkevich B (2008) Urochordate histoincompatible interactions activate vertebrate-like coagulation system components. PLoS One 3(9):e3123. https://doi.org/10.1371/journal.pone.0003123 PubMedPubMedCentral

53.

Raftos DA, Tait NN, Briscoe DA (1987) Cellular basis of allograft rejection in the solitary urochordate, Styela plicata. Dev Comp Immunol 11(4):713–725PubMed

54.

Voehringer D (2013) Protective and pathological roles of mast cells and basophils. Nat Rev Immunol 13(5):362–375. https://doi.org/10.1038/nri3427 PubMed

55.

Arock M (2016) Mast cell differentiation: still open questions? Blood 127(4):373–374. https://doi.org/10.1182/blood-2015-12-686592 PubMed

56.

Dahlin JS, Malinovschi A, Ohrvik H, Sandelin M (2016) Lin-CD34hi CD117int/hi FcepsilonRI+ cells in human blood constitute a rare population of mast cell progenitors. Blood 127(4):383–391. https://doi.org/10.1182/blood-2015-06-650648 PubMedPubMedCentral

57.

Okayama Y, Kawakami T (2006) Development, migration, and survival of mast cells. Immunol Res 34(2):97–115. https://doi.org/10.1385/ir:34:2:97 PubMedPubMedCentral

58.

Xu Y, Chen G (2015) Mast cell and autoimmune diseases. Mediat Inflamm 2015:246126. https://doi.org/10.1155/2015/246126

59.

Grimbaldeston MA, Simpson A, Finlay-Jones JJ, Hart PH (2003) The effect of ultraviolet radiation exposure on the prevalence of mast cells in human skin. Br J Dermatol 148(2):300–306. https://doi.org/10.1046/j.1365-2133.2003.05113.x PubMed

60.

Kim MS, Kim YK, Lee DH, Seo JE, Cho KH, Eun HC, Chung JH (2009) Acute exposure of human skin to ultraviolet or infrared radiation or heat stimuli increases mast cell numbers and tryptase expression in human skin in vivo. Br J Dermatol 160(2):393–402. https://doi.org/10.1111/j.1365-2133.2008.08838.x PubMed

61.

Migalovich-Sheikhet H, Friedman S, Mankuta D, Levi-Schaffer F (2012) Novel identified receptors on mast cells. Front Immunol 3:238. https://doi.org/10.3389/fimmu.2012.00238 PubMedPubMedCentral

62.

Gilfillan AM, Beaven MA (2011) Regulation of mast cell responses in health and disease. Crit Rev Immunol 31(6):475–529PubMedPubMedCentral

63.

Halova I, Draberova L, Draber P (2012) Mast cell chemotaxis - chemoattractants and signaling pathways. Front Immunol 3:119. https://doi.org/10.3389/fimmu.2012.00119 PubMedPubMedCentral

64.

Bulanova E, Bulfone-Paus S (2010) P2 receptor-mediated signaling in mast cell biology. Purinergic Signal 6(1):3–17. https://doi.org/10.1007/s11302-009-9173-z PubMed

65.

Stone KD, Prussin C, Metcalfe DD (2010) IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 125(2 Suppl 2):S73–S80. https://doi.org/10.1016/j.jaci.2009.11.017 PubMedPubMedCentral

66.

Kulka M, Metcalfe DD (2010) Isolation of tissue mast cells. Current protocols in immunology Chapter 7:Unit 7.25. https://doi.org/10.1002/0471142735.im0725s90

67.

Mizrahi S, Gibbs BF, Karra L, Ben-Zimra M, Levi-Schaffer F (2014) Siglec-7 is an inhibitory receptor on human mast cells and basophils. J Allergy Clin Immunol 134(1):230–233. https://doi.org/10.1016/j.jaci.2014.03.031 PubMed

68.

O’Sullivan JA, Carroll DJ, Cao Y, Salicru AN, Bochner BS (2017) Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2017.06.028 PubMed

69.

Kiwamoto T, Kawasaki N, Paulson JC, Bochner BS (2012) Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. Pharmacol Ther 135(3):327–336. https://doi.org/10.1016/j.pharmthera.2012.06.005 PubMedPubMedCentral

70.

Meixiong J, Anderson M, Limjunyawong N, Sabbagh MF, Hu E, Mack MR, Oetjen LK, Wang F, Kim BS, Dong X (2019) Activation of mast-cell-expressed mas-related G-protein-coupled receptors drives non-histaminergic itch. Immunity 50(5):1163–1171.e1165. https://doi.org/10.1016/j.immuni.2019.03.013 PubMedPubMedCentral

71.

Green DP, Limjunyawong N, Gour N, Pundir P, Dong X (2019) A mast-cell-specific receptor mediates neurogenic inflammation and pain. Neuron 101(3):412–420.e413. https://doi.org/10.1016/j.neuron.2019.01.012 PubMedPubMedCentral

72.

Frieri M, Patel R, Celestin J (2013) Mast cell activation syndrome: a review. Curr Allergy Asthma Rep 13(1):27–32. https://doi.org/10.1007/s11882-012-0322-z PubMed

73.

Blechman JM, Lev S, Givol D, Yarden Y (1993) Structure-function analyses of the kit receptor for the steel factor. Stem Cells (Dayton, Ohio) 11(Suppl 2):12–21. https://doi.org/10.1002/stem.5530110804

74.

Besmer P, Manova K, Duttlinger R, Huang EJ, Packer A, Gyssler C, Bachvarova RF (1993) The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis. Development (Cambridge, Engl) Supplement:125–137

75.

Gilfillan AM, Rivera J (2009) The tyrosine kinase network regulating mast cell activation. Immunol Rev 228(1):149–169. https://doi.org/10.1111/j.1600-065X.2008.00742.x PubMedPubMedCentral

76.

Alvarez-Errico D, Lessmann E, Rivera J (2009) Adapters in the organization of mast cell signaling. Immunol Rev 232(1):195–217. https://doi.org/10.1111/j.1600-065X.2009.00834.x PubMedPubMedCentral

77.

Silveira ESAM, Mazucato VM, Jamur MC, Oliver C (2011) Lipid rafts in mast cell biology. J Lipids 2011:752906. https://doi.org/10.1155/2011/752906

78.

Blank U, Rivera J (2004) The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol 25(5):266–273. https://doi.org/10.1016/j.it.2004.03.005 PubMed

79.

Draber P, Sulimenko V, Draberova E (2012) Cytoskeleton in mast cell signaling. Front Immunol 3:130. https://doi.org/10.3389/fimmu.2012.00130 PubMedPubMedCentral

80.

Siraganian RP, de Castro RO, Barbu EA, Zhang J (2010) Mast cell signaling: the role of protein tyrosine kinase Syk, its activation and screening methods for new pathway participants. FEBS Lett 584(24):4933–4940. https://doi.org/10.1016/j.febslet.2010.08.006 PubMedPubMedCentral

81.

Blank U, Madera-Salcedo IK, Danelli L, Claver J, Tiwari N, Sanchez-Miranda E, Vazquez-Victorio G, Ramirez-Valadez KA, Macias-Silva M, Gonzalez-Espinosa C (2014) Vesicular trafficking and signaling for cytokine and chemokine secretion in mast cells. Front Immunol 5:453. https://doi.org/10.3389/fimmu.2014.00453 PubMedPubMedCentral

82.

Moon TC, Befus AD, Kulka M (2014) Mast cell mediators: their differential release and the secretory pathways involved. Front Immunol 5:569. https://doi.org/10.3389/fimmu.2014.00569 PubMedPubMedCentral

83.

Hammel I, Lagunoff D, Galli SJ (2010) Regulation of secretory granule size by the precise generation and fusion of unit granules. J Cell Mol Med 14(7):1904–1916. https://doi.org/10.1111/j.1582-4934.2010.01071.x PubMedPubMedCentral

84.

Azouz NP, Hammel I, Sagi-Eisenberg R (2014) Characterization of mast cell secretory granules and their cell biology. DNA Cell Biol 33(10):647–651. https://doi.org/10.1089/dna.2014.2543 PubMedPubMedCentral

85.

Lorentz A, Baumann A, Vitte J, Blank U (2012) The SNARE machinery in mast cell secretion. Front Immunol 3:143. https://doi.org/10.3389/fimmu.2012.00143 PubMedPubMedCentral

86.

Woska JR Jr, Gillespie ME (2012) SNARE complex-mediated degranulation in mast cells. J Cell Mol Med 16(4):649–656. https://doi.org/10.1111/j.1582-4934.2011.01443.x PubMedPubMedCentral

87.

Puri N, Roche PA (2008) Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Natl Acad Sci U S A 105(7):2580–2585. https://doi.org/10.1073/pnas.0707854105 PubMedPubMedCentral

88.

Cabeza JM, Acosta J, Ales E (2013) Mechanisms of granule membrane recapture following exocytosis in intact mast cells. J Biol Chem 288(28):20293–20305. https://doi.org/10.1074/jbc.M113.459065 PubMedPubMedCentral

89.

Garcia-Faroldi G, Rodriguez CE, Urdiales JL, Perez-Pomares JM, Davila JC, Pejler G, Sanchez-Jimenez F, Fajardo I (2010) Polyamines are present in mast cell secretory granules and are important for granule homeostasis. PLoS One 5(11):e15071. https://doi.org/10.1371/journal.pone.0015071 PubMedPubMedCentral

90.

Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati A, Kalogeromitros D (2012) Mast cells and inflammation. Biochim Biophys Acta 1822(1):21–33. https://doi.org/10.1016/j.bbadis.2010.12.014 PubMed

91.

Metcalfe DD, Pawankar R, Ackerman SJ, Akin C, Clayton F, Falcone FH, Gleich GJ, Irani AM, Johansson MW, Klion AD, Leiferman KM, Levi-Schaffer F, Nilsson G, Okayama Y, Prussin C, Schroeder JT, Schwartz LB, Simon HU, Walls AF, Triggiani M (2016) Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases. World Allergy Organ J 9:7. https://doi.org/10.1186/s40413-016-0094-3 PubMedPubMedCentral

92.

Wernersson S, Pejler G (2014) Mast cell secretory granules: armed for battle. Nat Rev Immunol 14(7):478–494. https://doi.org/10.1038/nri3690 PubMed

93.

Caughey GH (2011) Mast cell proteases as protective and inflammatory mediators. Adv Exp Med Biol 716:212–234. https://doi.org/10.1007/978-1-4419-9533-9_12 PubMedPubMedCentral

94.

Lefrancais E, Duval A, Mirey E, Roga S, Espinosa E, Cayrol C, Girard JP (2014) Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc Natl Acad Sci U S A 111(43):15502–15507. https://doi.org/10.1073/pnas.1410700111 PubMedPubMedCentral

95.

Le QT, Gomez G, Zhao W, Hu J, Xia HZ, Fukuoka Y, Katunuma N, Schwartz LB (2011) Processing of human protryptase in mast cells involves cathepsins L, B, and C. J Immunol (Baltimore, Md : 1950) 187(4):1912–1918. https://doi.org/10.4049/jimmunol.1001806

96.

Caughey GH (2007) Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 217:141–154. https://doi.org/10.1111/j.1600-065X.2007.00509.x PubMedPubMedCentral

97.

Trivedi NN, Caughey GH (2010) Mast cell peptidases: chameleons of innate immunity and host defense. Am J Respir Cell Mol Biol 42(3):257–267. https://doi.org/10.1165/rcmb.2009-0324RT PubMed

98.

Galli SJ, Grimbaldeston M, Tsai M (2008) Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8(6):478–486. https://doi.org/10.1038/nri2327 PubMedPubMedCentral

99.

Henningsson F, Yamamoto K, Saftig P, Reinheckel T, Peters C, Knight SD, Pejler G (2005) A role for cathepsin E in the processing of mast-cell carboxypeptidase a. J Cell Sci 118(Pt 9):2035–2042. https://doi.org/10.1242/jcs.02333 PubMed

100.

He SH, Zhang HY, Zeng XN, Chen D, Yang PC (2013) Mast cells and basophils are essential for allergies: mechanisms of allergic inflammation and a proposed procedure for diagnosis. Acta Pharmacol Sin 34(10):1270–1283. https://doi.org/10.1038/aps.2013.88 PubMedPubMedCentral

101.

Parameswaran K, Radford K, Fanat A, Stephen J, Bonnans C, Levy BD, Janssen LJ, Cox PG (2007) Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines. Am J Respir Cell Mol Biol 37(2):240–247. https://doi.org/10.1165/rcmb.2006-0172OC PubMed

102.

Kasperska-Zajac A, Brzoza Z, Rogala B (2008) Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy. Recent Patents Inflamm Allergy Drug Discov 2(1):72–76

103.

Huttunen M, Aalto ML, Harvima RJ, Horsmanheimo M, Harvima IT (2000) Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic wounds. Exp Dermatol 9(4):258–265PubMed

104.

KleinJan A (2016) Airway inflammation in asthma: key players beyond the Th2 pathway. Curr Opin Pulm Med 22(1):46–52. https://doi.org/10.1097/mcp.0000000000000224 PubMed

105.

Nakae S, Morita H, Ohno T, Arae K, Matsumoto K, Saito H (2013) Role of interleukin-33 in innate-type immune cells in allergy. Allergol Int Off J Jpn Soc Allergol 62(1):13–20. https://doi.org/10.2332/allergolint.13-RAI-0538

106.

de Vries VC, Noelle RJ (2010) Mast cell mediators in tolerance. Curr Opin Immunol 22(5):643–648. https://doi.org/10.1016/j.coi.2010.08.015 PubMed

107.

Shiota N, Nishikori Y, Kakizoe E, Shimoura K, Niibayashi T, Shimbori C, Tanaka T, Okunishi H (2010) Pathophysiological role of skin mast cells in wound healing after scald injury: study with mast cell-deficient W/W(V) mice. Int Arch Allergy Immunol 151(1):80–88. https://doi.org/10.1159/000232573 PubMed

108.

Wasiuk A, de Vries VC, Hartmann K, Roers A, Noelle RJ (2009) Mast cells as regulators of adaptive immunity to tumours. Clin Exp Immunol 155(2):140–146. https://doi.org/10.1111/j.1365-2249.2008.03840.x PubMedPubMedCentral

109.

Overed-Sayer C, Rapley L, Mustelin T, Clarke DL (2013) Are mast cells instrumental for fibrotic diseases? Front Pharmacol 4:174. https://doi.org/10.3389/fphar.2013.00174 PubMed

110.

Waern I, Karlsson I, Pejler G, Wernersson S (2016) IL-6 and IL-17A degradation by mast cells is mediated by a serglycin:serine protease axis. Immun Inflamm Dis 4(1):70–79. https://doi.org/10.1002/iid3.95 PubMed

111.

Dichlberger A, Kovanen PT, Schneider WJ (2013) Mast cells: from lipid droplets to lipid mediators. Clin Sci (Lond, Engl : 1979) 125(3):121–130. https://doi.org/10.1042/cs20120602

112.

Nocka K, Majumder S, Chabot B, Ray P, Cervone M, Bernstein A, Besmer P (1989) Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice. Genes Dev 3(6):816–826PubMed

113.

Ronnstrand L (2004) Signal transduction via the stem cell factor receptor/c-kit. Cell Mol Life Sci CMLS 61(19–20):2535–2548. https://doi.org/10.1007/s00018-004-4189-6 PubMed

114.

Reber LL, Marichal T, Galli SJ (2012) New models for analyzing mast cell functions in vivo. Trends Immunol 33(12):613–625. https://doi.org/10.1016/j.it.2012.09.008 PubMedPubMedCentral

115.

Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M (2005) Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23:749–786. https://doi.org/10.1146/annurev.immunol.21.120601.141025 PubMed

116.

Wedemeyer J, Galli SJ (2005) Decreased susceptibility of mast cell-deficient kit(W)/kit(W-v) mice to the development of 1, 2-dimethylhydrazine-induced intestinal tumors. Lab Invest J Tech Methods Pathol 85(3):388–396. https://doi.org/10.1038/labinvest.3700232

117.

Galli SJ, Tsai M (2010) Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol 40(7):1843–1851. https://doi.org/10.1002/eji.201040559 PubMedPubMedCentral

118.

Duttlinger R, Manova K, Chu TY, Gyssler C, Zelenetz AD, Bachvarova RF, Besmer P (1993) W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. Development (Cambridge, England) 118(3):705–717

119.

Chmelar J, Chatzigeorgiou A, Chung KJ, Prucnal M, Voehringer D, Roers A, Chavakis T (2016) No role for mast cells in obesity-related metabolic dysregulation. Front Immunol 7:524. https://doi.org/10.3389/fimmu.2016.00524 PubMedPubMedCentral

120.

Feyerabend TB, Weiser A, Tietz A, Stassen M, Harris N, Kopf M, Radermacher P, Moller P, Benoist C, Mathis D, Fehling HJ, Rodewald HR (2011) Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity 35(5):832–844. https://doi.org/10.1016/j.immuni.2011.09.015 PubMed

121.

Feyerabend TB, Gutierrez DA, Rodewald HR (2016) Of mouse models of mast cell deficiency and metabolic syndrome. Cell Metab 24(1):1–2. https://doi.org/10.1016/j.cmet.2016.06.019 PubMed

122.

Lei Y, Gregory JA, Nilsson GP, Adner M (2013) Insights into mast cell functions in asthma using mouse models. Pulm Pharmacol Ther 26(5):532–539. https://doi.org/10.1016/j.pupt.2013.03.019 PubMed

123.

Elieh Ali Komi D, Rambasek T, Bielory L (2018) Clinical implications of mast cell involvement in allergic conjunctivitis. Allergy 73(3):528–539. https://doi.org/10.1111/all.13334 PubMed

124.

Church MK, Kolkhir P, Metz M, Maurer M (2018) The role and relevance of mast cells in urticaria. Immunol Rev 282(1):232–247. https://doi.org/10.1111/imr.12632 PubMed

125.

Lee CC, Lin CL, Leu SJ, Lee YL (2018) Overexpression of notch ligand Delta-like-1 by dendritic cells enhances their immunoregulatory capacity and exerts antiallergic effects on Th2-mediated allergic asthma in mice. Clin Immunol (Orlando, FL) 187:58–67. https://doi.org/10.1016/j.clim.2017.10.005

126.

Galli SJ, Tsai M (2012) IgE and mast cells in allergic disease. Nat Med 18(5):693–704. https://doi.org/10.1038/nm.2755 PubMedPubMedCentral

127.

Ciprandi G, Marseglia GL, Castagnoli R, Valsecchi C, Tagliacarne C, Caimmi S, Licari A (2015) From IgE to clinical trials of allergic rhinitis. Expert Rev Clin Immunol 11(12):1321–1333. https://doi.org/10.1586/1744666x.2015.1086645 PubMed

128.

Shamji MH, Durham SR (2017) Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J Allergy Clin Immunol 140(6):1485–1498. https://doi.org/10.1016/j.jaci.2017.10.010 PubMed

129.

Modena BD, Dazy K, White AA (2016) Emerging concepts: mast cell involvement in allergic diseases. Transl Res J Lab Clin Med 174:98–121. https://doi.org/10.1016/j.trsl.2016.02.011

130.

Brown MA, Hatfield JK (2012) Mast cells are important modifiers of autoimmune disease: with so much evidence, why is there still controversy? Front Immunol 3:147. https://doi.org/10.3389/fimmu.2012.00147 PubMedPubMedCentral

131.

Rivellese F, Nerviani A, Rossi FW, Marone G, Matucci-Cerinic M, de Paulis A, Pitzalis C (2017) Mast cells in rheumatoid arthritis: friends or foes? Autoimmun Rev 16(6):557–563. https://doi.org/10.1016/j.autrev.2017.04.001 PubMed

132.

Sato K, Takayanagi H (2006) Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol 18(4):419–426. https://doi.org/10.1097/01.bor.0000231912.24740.a5 PubMed

133.

Elieh-Ali-Komi D, Cao Y (2016) Role of mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Rev Allergy Immunol. https://doi.org/10.1007/s12016-016-8595-y

134.

Theoharides TC, Kempuraj D, Kourelis T, Manola A (2008) Human mast cells stimulate activated T cells: implications for multiple sclerosis. Ann N Y Acad Sci 1144:74–82. https://doi.org/10.1196/annals.1418.029 PubMed

135.

Conti P, Kempuraj D (2016) Important role of mast cells in multiple sclerosis. Mult Scler Relat Disord 5:77–80. https://doi.org/10.1016/j.msard.2015.11.005 PubMed

136.

Medic N, Vita F, Abbate R, Soranzo MR, Pacor S, Fabbretti E, Borelli V, Zabucchi G (2008) Mast cell activation by myelin through scavenger receptor. J Neuroimmunol 200(1–2):27–40. https://doi.org/10.1016/j.jneuroim.2008.05.019 PubMed

137.

Li H, Nourbakhsh B, Safavi F, Li K, Xu H, Cullimore M, Zhou F, Zhang G, Rostami A (2011) Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression. J Immunol (Baltimore, Md : 1950) 187(1):274–282. https://doi.org/10.4049/jimmunol.1003603

138.

Komi DEA, Redegeld FA (2019) Role of mast cells in shaping the tumor microenvironment. Clin Rev Allergy Immunol. https://doi.org/10.1007/s12016-019-08753-w

139.

Rigoni A, Colombo MP, Pucillo C (2015) The role of mast cells in molding the tumor microenvironment. Cancer Microenviron Off J Int Cancer Microenviron Soc 8(3):167–176. https://doi.org/10.1007/s12307-014-0152-8

140.

Huang B, Lei Z, Zhang GM, Li D, Song C, Li B, Liu Y, Yuan Y, Unkeless J, Xiong H, Feng ZH (2008) SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 112(4):1269–1279. https://doi.org/10.1182/blood-2008-03-147033 PubMedPubMedCentral

141.

Maciel TT, Moura IC, Hermine O (2015) The role of mast cells in cancers. F1000prime reports 7:09. https://doi.org/10.12703/p7-09

142.

Gounaris E, Blatner NR, Dennis K, Magnusson F, Gurish MF, Strom TB, Beckhove P, Gounari F, Khazaie K (2009) T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res 69(13):5490–5497. https://doi.org/10.1158/0008-5472.Can-09-0304 PubMedPubMedCentral

143.

Danelli L, Frossi B, Pucillo CE (2015) Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment. Oncoimmunology 4(4):e1001232. https://doi.org/10.1080/2162402x.2014.1001232 PubMedPubMedCentral

144.

Ryan JJ, Morales JK, Falanga YT, Fernando JF, Macey MR (2009) Mast cell regulation of the immune response. World Allergy Organ J 2(10):224–232. https://doi.org/10.1097/WOX.0b013e3181c2a95e PubMedPubMedCentral

145.

Wulff BC, Wilgus TA (2013) Mast cell activity in the healing wound: more than meets the eye? Exp Dermatol 22(8):507–510. https://doi.org/10.1111/exd.12169 PubMedPubMedCentral

146.

Kennelly R, Conneely JB, Bouchier-Hayes D, Winter DC (2011) Mast cells in tissue healing: from skin to the gastrointestinal tract. Curr Pharm Des 17(34):3772–3775PubMed

147.

Ng MF (2010) The role of mast cells in wound healing. Int Wound J 7(1):55–61. https://doi.org/10.1111/j.1742-481X.2009.00651.x PubMed

148.

Trautmann A, Toksoy A, Engelhardt E, Brocker EB, Gillitzer R (2000) Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo. J Pathol 190(1):100–106. https://doi.org/10.1002/(sici)1096-9896(200001)190:1<100::aid-path496>3.0.co;2-q PubMed

149.

Tellechea A, Leal EC, Kafanas A, Auster ME, Kuchibhotla S, Ostrovsky Y, Tecilazich F, Baltzis D, Zheng Y, Carvalho E, Zabolotny JM, Weng Z, Petra A, Patel A, Panagiotidou S, Pradhan-Nabzdyk L, Theoharides TC, Veves A (2016) Mast cells regulate wound healing in diabetes. Diabetes 65(7):2006–2019. https://doi.org/10.2337/db15-0340 PubMedPubMedCentral

150.

Artuc M, Hermes B, Steckelings UM, Grutzkau A, Henz BM (1999) Mast cells and their mediators in cutaneous wound healing--active participants or innocent bystanders? Exp Dermatol 8(1):1–16PubMed

151.

Rao KN, Brown MA (2008) Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann N Y Acad Sci 1143:83–104. https://doi.org/10.1196/annals.1443.023 PubMed

152.

Mekori YA, Hershko AY (2012) T cell-mediated modulation of mast cell function: heterotypic adhesion-induced stimulatory or inhibitory effects. Front Immunol 3:6. https://doi.org/10.3389/fimmu.2012.00006 PubMedPubMedCentral

153.

Martin RK, Saleem SJ, Folgosa L, Zellner HB, Damle SR, Nguyen GK, Ryan JJ, Bear HD, Irani AM, Conrad DH (2014) Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cells. J Leukoc Biol 96(1):151–159. https://doi.org/10.1189/jlb.5A1213-644R PubMedPubMedCentral

154.

Carroll-Portillo A, Cannon JL, te Riet J, Holmes A, Kawakami Y, Kawakami T, Cambi A, Lidke DS (2015) Mast cells and dendritic cells form synapses that facilitate antigen transfer for T cell activation. J Cell Biol 210(5):851–864. https://doi.org/10.1083/jcb.201412074 PubMedPubMedCentral

155.

Galli SJ, Nakae S, Tsai M (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6(2):135–142. https://doi.org/10.1038/ni1158 PubMed

156.

Dahdah A, Gautier G, Attout T, Fiore F, Lebourdais E, Msallam R, Daeron M, Monteiro RC, Benhamou M, Charles N, Davoust J, Blank U, Malissen B, Launay P (2014) Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis. J Clin Invest 124(10):4577–4589. https://doi.org/10.1172/jci75212 PubMedPubMedCentral

157.

De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, Gunzer M, Roers A, Hogg N (2013) Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121(24):4930–4937. https://doi.org/10.1182/blood-2013-02-486217 PubMed

158.

Hodges K, Kennedy L, Meng F, Alpini G, Francis H (2012) Mast cells, disease and gastrointestinal cancer: a comprehensive review of recent findings. Transl Gastrointest Cancer 1(2):138–150PubMedPubMedCentral

159.

Schramm R, Thorlacius H (2004) Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoids. Inflamm Res Off J Eur Histamine Res Soc 53(12):644–652. https://doi.org/10.1007/s00011-004-1307-8

160.

Symowski C, Voehringer D (2017) Interactions between innate lymphoid cells and cells of the innate and adaptive immune system. Front Immunol 8:1422. https://doi.org/10.3389/fimmu.2017.01422 PubMedPubMedCentral

161.

Ganeshan K, Bryce PJ (2012) Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-beta. J Immunol (Baltimore, Md : 1950) 188(2):594–603. https://doi.org/10.4049/jimmunol.1102389

162.

de Vries VC, Wasiuk A, Bennett KA, Benson MJ, Elgueta R, Waldschmidt TJ, Noelle RJ (2009) Mast cell degranulation breaks peripheral tolerance. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 9(10):2270–2280. https://doi.org/10.1111/j.1600-6143.2009.02755.x

163.

Hershko AY, Rivera J (2010) Mast cell and T cell communication; amplification and control of adaptive immunity. Immunol Lett 128(2):98–104. https://doi.org/10.1016/j.imlet.2009.10.013 PubMed

164.

Satoh T, Akira S (2016) Toll-like receptor signaling and its inducible proteins. Microbiol Spectr 4(6). https://doi.org/10.1128/microbiolspec.MCHD-0040-2016

165.

Leifer CA, Medvedev AE (2016) Molecular mechanisms of regulation of toll-like receptor signaling. J Leukoc Biol 100(5):927–941. https://doi.org/10.1189/jlb.2MR0316-117RR PubMedPubMedCentral

166.

St John AL, Abraham SN (2013) Innate immunity and its regulation by mast cells. J Immunol (Baltimore, Md : 1950) 190(9):4458–4463. https://doi.org/10.4049/jimmunol.1203420

167.

Abraham SN, St John AL (2010) Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 10(6):440–452. https://doi.org/10.1038/nri2782 PubMedPubMedCentral

168.

Chan CY, St John AL, Abraham SN (2012) Plasticity in mast cell responses during bacterial infections. Curr Opin Microbiol 15(1):78–84. https://doi.org/10.1016/j.mib.2011.10.007 PubMed

169.

Saluja R, Metz M, Maurer M (2012) Role and relevance of mast cells in fungal infections. Front Immunol 3:146. https://doi.org/10.3389/fimmu.2012.00146 PubMedPubMedCentral

170.

Carlos D, Frantz FG, Souza-Junior DA, Jamur MC, Oliver C, Ramos SG, Quesniaux VF, Ryffel B, Silva CL, Bozza MT, Faccioli LH (2009) TLR2-dependent mast cell activation contributes to the control of mycobacterium tuberculosis infection. Microbes Infect 11(8–9):770–778. https://doi.org/10.1016/j.micinf.2009.04.025 PubMed

171.

Sutherland RE, Olsen JS, McKinstry A, Villalta SA, Wolters PJ (2008) Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J Immunol (Baltimore, Md : 1950) 181(8):5598–5605

172.

Junkins RD, Carrigan SO, Wu Z, Stadnyk AW, Cowley E, Issekutz T, Berman J, Lin TJ (2014) Mast cells protect against Pseudomonas aeruginosa-induced lung injury. Am J Pathol 184(8):2310–2321. https://doi.org/10.1016/j.ajpath.2014.05.009 PubMed

173.

Siebenhaar F, Syska W, Weller K, Magerl M, Zuberbier T, Metz M, Maurer M (2007) Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. Am J Pathol 170(6):1910–1916. https://doi.org/10.2353/ajpath.2007.060770 PubMedPubMedCentral

174.

Walker ME, Hatfield JK, Brown MA (2012) New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action? Biochim Biophys Acta 1822(1):57–65. https://doi.org/10.1016/j.bbadis.2011.02.009 PubMed

175.

Wang Z, Lai Y, Bernard JJ, Macleod DT, Cogen AL, Moss B, Di Nardo A (2012) Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides. J Immunol (Baltimore, Md : 1950) 188(1):345–357. https://doi.org/10.4049/jimmunol.1101703

176.

Aoki R, Kawamura T, Goshima F, Ogawa Y, Nakae S, Nakao A, Moriishi K, Nishiyama Y, Shimada S (2013) Mast cells play a key role in host defense against herpes simplex virus infection through TNF-alpha and IL-6 production. J Invest Dermatol 133(9):2170–2179. https://doi.org/10.1038/jid.2013.150 PubMed

177.

Choi HW, Abraham SN (2015) Mast cell mediator responses and their suppression by pathogenic and commensal microorganisms. Mol Immunol 63(1):74–79. https://doi.org/10.1016/j.molimm.2014.02.006 PubMed

178.

Elieh Ali Komi D, Shafaghat F, Zwiener RD (2017) Immunology of bee venom. Clin Rev Allergy Immunol. https://doi.org/10.1007/s12016-017-8597-4

179.

Galli SJ, Starkl P, Marichal T, Tsai M (2017) Mast cells and IgE can enhance survival during innate and acquired host responses to venoms. Trans Am Clin Climatol Assoc 128:193–221PubMedPubMedCentral

Title: Mast Cell Biology at Molecular Level: a Comprehensive Review
Authors: Daniel Elieh Ali Komi
Stefan Wöhrl
Leonard Bielory
Publication date: 01-06-2020
Publisher: Springer US
Published in: Clinical Reviews in Allergy & Immunology / Issue 3/2020
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-019-08769-2

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2020

Role of Mast Cells in Shaping the Tumor Microenvironment

Bee Venom Immunotherapy: Current Status and Future Directions

The Role of Mast Cells in IgE-Independent Lung Diseases

Using Baseline and Peak Serum Tryptase Levels to Diagnose Anaphylaxis: a Review

Crosstalk Between Mast Cells and Adipocytes in Physiologic and Pathologic Conditions

The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage